Hyderabad: Aurobindo Pharma said on Monday that it has acquired the domestic formulation business of Veritaz Healthcare on a slump sale basis. The transaction was agreed at a consideration of Rs 171 crore on a debt-free cash-free basis. The transaction comes into effect from April 1 and is expected to close by May 2022. This […]
Hyderabad: Three pharma companies from Hyderabad have entered into agreement with UN-backed Medicines Patent Pool (MPP), headquartered in Geneva, to manufacture and supply a generic version of Pfizer’s Covid-19 oral treatment Nirmatrelvir. Aurobindo Pharma said it signed a sub-license agreement with MPP. Earlier, MPP signed voluntary licensing agreement with Pfizer for sub-licensing this Covid-19 treatment […]
Hyderabad: To ensure quality tertiary cancer care facilities are available for free of cost to needy patients, the Telangana government in collaboration with voluntary organisations is developing crucial medical infrastructure at city-based MNJ Cancer Hospital with a cost of over Rs. 95 crore. As part of these efforts, on Friday, which also coincides with World […]
New Delhi: Aurobindo Pharma on Friday said it has received a warning letter from the US health regulator for its Hyderabad-based Unit I, an API (active pharmaceutical ingredient) manufacturing facility. The action follows the recent inspection of the facility by the US Food and Drug Administration (USFDA) in August 2021, the drugmaker said in a […]
Hyderabad: Proving once again that Hyderabad is rightly called the pharmaceutical hub of India, three billionaires featured in the top 100 India Rich List are from this sector and from the city as well. Murali Divi of Divi Labs is the richest Hyderabadi and is ranked the 14th richest person in the country with 61 […]
